Global Hypodermic Syringes Market to Surpass US$ 4.66 Billion by 2032, Growing at a CAGR of 3.2% from 2022 to 2032

FMI

Over the projected period from 2022 to 2032, it is anticipated that the global hypodermic syringes market will expand at a static CAGR of 3.2%. The global market was estimated to be worth US$ 3.51 billion in 2022, and it is anticipated that by 2032, it will generate US$ 4.66 billion in sales. During the projected period, it is anticipated that the expansion of the worldwide hypodermic syringes market would exhibit excellent growth possibilities, increasing the market size for these devices.

The word hypodermic, from the Greek “hypo” (below), means variously applied. Contrarily, the word “derm” refers to skin, which explains why hypodermic needles are used to draw fluid from or inject fluid into the body.

Additionally, the use of these syringes has increased over the past several years and will continue to do so over the foreseeable future due to the rise in chronic diseases. The medical industry’s need for hypodermic syringes is also fueled by the relaxing factor.

For More Insights on this Market, Get A Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9423

The leading government initiatives and dosing errors related to syringes, according to a new research report on the worldwide hypodermic syringes market, have propelled the sales of hypodermic syringes in healthcare markets. In addition, aggressive pricing ranges and new business models are some additional aspects that support the growth of the hypodermic syringes industry. This will probably increase demand for hypodermic syringes.

Key Takeaways

  • The global hypodermic syringes market is anticipated to flourish under the backdrop of the global pharmaceutical industry throughout the projection period. In addition to that, hypodermic syringes are preferred when compared to the after-filled syringes as they offer fixed dosages of the drug and ease in usability.
  • Prefill ability is expected to assist in reducing the overall cost by decreasing the drug overfill. Moreover, single-dose vials or multi-dose vials have a drug overfill of almost 20-25% so that the administrator has enough to fill the correct dose and to compensate for human errors, flourishing the demand for hypodermic syringes.
  • The prefilled hypodermic syringes eradicate the source of inefficiency within the manufacturing processes by efficiently eliminating drug overfills. Furthermore, this is considered a particularly advantageous component for numerous companies dealing with costly biopharmaceuticals. The growth of the biologics market is likely to boost the hypodermic syringes market.
  • The conventional syringes were built with glass barrels and glass rods, which were estimated to be expensive to manufacture when compared to plastic-based hypodermic syringes, pushing the sales of hypodermic syringes globally.
  • Healthcare workers are likely to benefit from accurate and pre-measured doses. The surging demand for hypodermic syringes is also anticipated to be fueled due to reduced dosage, medication errors along with decreased microbial contamination risk. Along with this, an increasing trend of people getting vaccinated outside hospitals such as in schools, community centers, pharmacies, and airport booths is likely to contribute to the growth of the hypodermic syringes market.

Get 20% Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-9423

Competitive Landscape

The key players within the hypodermic syringes market are focusing on mergers and collaborations that are expected to propel the sales of hypodermic syringes throughout the assessment period. Several prominent market players are working on introducing hypodermic syringes with a needle that has an integrated plunger stop to help prevent the plunger from being pulled out. These fuels the sales of hypodermic syringes.

Furthermore, new components within the manufacturing units are being produced by introducing disposable syringes & needles for national and international standards. This increases the demand for hypodermic syringes. Other regional companies have also launched their new set of hypodermic syringes which are the type of devices that have a wide range of clinical applications, increasing the demand for hypodermic syringes.

More Insights into the Hypodermic Syringes Market

On the basis of geographic landscape, the global hypodermic syringes market has been divided into seven key regions: North America, Latin America, East Asia, South Asia, Europe, Middle East & Africa (MEA), and Oceania.

Europe is expected to dominate the global hypodermic syringes market as it is expected to hold the maximum market share in the global hypodermic syringes market owing to the well-established healthcare industry in the region.

The healthcare sector in developing economies like India is diversifying and is expected to offer opportunities in every segment, which incorporates payers, providers, and medical technology. Increasing competition pushing businesses to explore and adapt according to the latest trends and dynamics is expected to impact the hypodermic syringes market in the country positively.

Request for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-9423

Key Segments In The Hypodermic Syringes Market

By Material Type:

  • Polymer Syringes
  • Cyclic Olefin Polymers (COP)
  • Cyclic Olefin Copolymers (COC)
  • Polypropylene and Other Polymers
  • Glass Syringes

By Sales Channel:

  • Manufacturers
  • Distributors
  • Retailers

By End User:

  • Hospital
  • Diabetic Care Centers
  • Blood Collection Centers
  • Veterinary Care Centers
  • Clinics

About Us:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these